{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:21:10Z","timestamp":1762176070899},"reference-count":39,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> To establish the clinicopathologic and familial differences within Amsterdam I\u2013positive families, showing either tumor microsatellite instability (MSI) or microsatellite stability (MSS) in order to confirm or deny the existence of hereditary nonpolyposis colorectal cancer (HNPCC) without defects in the mismatch repair system. <\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p> Sixty-four Amsterdam I\u2013positive families were included in the study for which full, three-generation, family medical histories and colorectal paraffin-embedded tumors were obtained. Both personal and clinicopathologic information of patients were collected. In all cases, both the MSI status and the mismatch repair (MMR) protein expression were analyzed. MMR genetic testing was performed on the MSI families. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Of the Amsterdam I\u2013positive families, 59.4% were tumor MSI, and 40.6% were tumor MSS. When comparing both groups, the statistical differences were observed in the age of onset (MSI, 41 years; MSS, 53 years); in the colorectal tumor location, more frequently proximal in MSI cases; in fewer mucinous tumors in MSS; and loss of MMR protein expression in the MSI tumors. Regarding the individual and familial cancer history, we observed a predominance of individuals with multiple primary tumors in MSI pedigrees, as well as differences in the type of tumors developed within the family. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> Our findings support the suspicion of another hereditary colorectal syndrome different from HNPCC and characterized by MSS, the normal MMR immunohistochemical expression, the presence of only colorectal tumors, and the absence of individuals with multiple primary tumors. All these circumstances suggest the existence of a non-MMR gene being responsible for this new syndrome. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2006.06.9781","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T03:28:59Z","timestamp":1169004539000},"page":"781-786","source":"Crossref","is-referenced-by-count":57,"title":["Clinicopathologic and Pedigree Differences in Amsterdam I\u2013Positive Hereditary Nonpolyposis Colorectal Cancer Families According to Tumor Microsatellite Instability Status"],"prefix":"10.1200","volume":"25","author":[{"given":"Laura","family":"Valle","sequence":"first","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Perea","sequence":"additional","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Carbonell","sequence":"additional","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Fernandez","sequence":"additional","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Dotor","sequence":"additional","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Benitez","sequence":"additional","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Urioste","sequence":"additional","affiliation":[{"name":"From the Familial Cancer Unit and the Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre; Tumor Bank Unit, Molecular Pathology Program, Spanish National Cancer Centre, Madrid; Surgery Department, Hospital de Segovia, Segovia; Molecular Genetics Unit, Centro de Bioqu\u00edmica y Gen\u00e9tica Cl\u00ednica, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1","unstructured":"Lynch HT, de la Chapelle A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801,1999-818,"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02053699"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70510-X"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.23.1758"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh034"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382101"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.6.839"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27996"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.11.2193"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1159\/000078223"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.060905"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.16.1979"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0965"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92902-9"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201584"},{"key":"R18","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248,1998-5257,"},{"key":"R19","unstructured":"Hoang JM, Cottu PH, Thuille B, et al: BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57:300,1997-303,"},{"key":"R20","unstructured":"Loukola A, Eklin K, Laiho P, et al: Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61:4545,2001-4549,"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Wang L, Bani-Hani A, Montoya DP, et al: HMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 19:567,2001-570,","DOI":"10.3892\/ijo.19.3.567"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2879"},{"key":"R24","unstructured":"Wijnen J, Khan PM, Vasen H, et al: Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet 58:300,1996-307,"},{"key":"R25","unstructured":"Wijnen J, Vasen H, Khan PM, et al: Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56:1060,1995-1066,"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Nakagawa H, Hampel H, de la Chapelle A: Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum Mutat 22:258,2003,","DOI":"10.1002\/humu.9171"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-7-200304010-00012"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1453"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.6.718"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.7.799"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.15.8698"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.12.6870"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.181"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1038\/386623a0"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.041603298"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204653"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208387"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.06.9781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:15:00Z","timestamp":1653513300000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.06.9781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,3,1]]}},"alternative-id":["10.1200\/JCO.2006.06.9781"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.06.9781","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}